Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs United Microelectronics Corp (UMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs United Microelectronics Corp — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $977.37M), while United Microelectronics Corp trades at $20.67 (market cap $55.41B). The key difference: United Microelectronics Corp is far larger — about 56.7× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and United Microelectronics Corp pays a 1.87% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and United Microelectronics Corp for 42 Days on average.
| MRVI | UMC | |
|---|---|---|
Market Cap | $977.37M | $55.41B |
Volume | 2,742,564 | 12,773,662 |
Sector | Health | Technology |
52-Week High | $9.00 | $28.02 |
52-Week Low | $2.83 | $7.02 |
Typical Hold Time | 0 Days | 42 Days |
Enterprise Value | $1.08B | $52.51B |
Dividend Yield | — | 1.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
UMC trades at $22.39, down 0.71% on the day, with a bullish technical signal despite recent volatility. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 EPS of $0.54 significantly exceeding the $0.16 forecast. Revenue is projected to grow to $250.7 billion in 2026, with a net income margin rebounding to 32.75%. Cash flow trends show improving operational performance, with net cash flow turning positive in 2025 at $5.66 billion.
The outlook is positive given strong earnings momentum and AI-driven demand, but risks include competitive pressures and sensitivity to semiconductor cycles. Analyst sentiment is mixed with a Hold consensus, though some upgrades to Strong Buy highlight growth potential. The stock's valuation multiples suggest room for appreciation if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About United Microelectronics Corp
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →
